Brilliant Violet 421 anti-human CD335 NKp46 Antibody anti-CD335 - 9E2,BioLegend,331913

Clone 9E2 has been shown to block NK activation through NKp46.6

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB450540632

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameBrilliant Violet 421 anti-human CD335 NKp46 Antibody anti-CD335 - 9E2
Cat. No.331913
HostMouse
RRIDAB_10916529 (BioLegend Cat. No. 331913)AB_2563853 (BioLegend Cat. No. 331914)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone Number900
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD335
ImmunogenNKp46-Fc fusion protein
PurityThe antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD335, also known as NKp46, is a member of the natural cytotoxicity receptor (NCR) family which triggers cytotoxicity in NK cells. CD335 is direct­ly involved in target cell recognition and lysis, and is exclusively expressed on CD3-CD56+NK cells, suggesting it is a universal marker for NK cells. NKp46, along with NKp30 and NKp44, is referred to as a natural cytoxicity receptor (NCR) and plays a very important role in killing virus-infected tumor cells and MHC-class I-unprotected cells.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.